US20020087207A1 - Optical radiation treatment for prevention of surgical scars - Google Patents
Optical radiation treatment for prevention of surgical scars Download PDFInfo
- Publication number
- US20020087207A1 US20020087207A1 US09/804,491 US80449101A US2002087207A1 US 20020087207 A1 US20020087207 A1 US 20020087207A1 US 80449101 A US80449101 A US 80449101A US 2002087207 A1 US2002087207 A1 US 2002087207A1
- Authority
- US
- United States
- Prior art keywords
- patient
- wound
- scar
- prevention
- skin
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 230000003287 optical effect Effects 0.000 title claims abstract description 24
- 230000005855 radiation Effects 0.000 title claims abstract description 24
- 230000002265 prevention Effects 0.000 title claims abstract description 19
- 238000011282 treatment Methods 0.000 title description 10
- 206010039580 Scar Diseases 0.000 title description 2
- 208000027418 Wounds and injury Diseases 0.000 claims abstract description 67
- 206010052428 Wound Diseases 0.000 claims abstract description 38
- 230000006378 damage Effects 0.000 claims abstract description 29
- 208000014674 injury Diseases 0.000 claims abstract description 29
- 231100000241 scar Toxicity 0.000 claims abstract description 29
- 238000000034 method Methods 0.000 claims abstract description 27
- 238000001356 surgical procedure Methods 0.000 claims abstract description 18
- 230000035876 healing Effects 0.000 claims abstract description 10
- 230000036573 scar formation Effects 0.000 claims description 7
- 230000037390 scarring Effects 0.000 claims description 2
- 210000001519 tissue Anatomy 0.000 description 10
- 230000015572 biosynthetic process Effects 0.000 description 9
- 210000003491 skin Anatomy 0.000 description 9
- 102000008186 Collagen Human genes 0.000 description 6
- 108010035532 Collagen Proteins 0.000 description 6
- 206010039509 Scab Diseases 0.000 description 6
- 210000004204 blood vessel Anatomy 0.000 description 6
- 229920001436 collagen Polymers 0.000 description 6
- 210000002950 fibroblast Anatomy 0.000 description 6
- 208000032544 Cicatrix Diseases 0.000 description 4
- 208000028990 Skin injury Diseases 0.000 description 4
- 210000004027 cell Anatomy 0.000 description 4
- 230000000694 effects Effects 0.000 description 4
- 239000013307 optical fiber Substances 0.000 description 4
- 230000037387 scars Effects 0.000 description 4
- 230000001413 cellular effect Effects 0.000 description 3
- 210000002615 epidermis Anatomy 0.000 description 3
- 210000000265 leukocyte Anatomy 0.000 description 3
- 210000001616 monocyte Anatomy 0.000 description 3
- XKRFYHLGVUSROY-UHFFFAOYSA-N Argon Chemical compound [Ar] XKRFYHLGVUSROY-UHFFFAOYSA-N 0.000 description 2
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 2
- 210000000601 blood cell Anatomy 0.000 description 2
- 230000001112 coagulating effect Effects 0.000 description 2
- 210000001339 epidermal cell Anatomy 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 230000009772 tissue formation Effects 0.000 description 2
- 102000008946 Fibrinogen Human genes 0.000 description 1
- 108010049003 Fibrinogen Proteins 0.000 description 1
- 208000002260 Keloid Diseases 0.000 description 1
- 229910052786 argon Inorganic materials 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 230000023555 blood coagulation Effects 0.000 description 1
- 210000001772 blood platelet Anatomy 0.000 description 1
- 229910002092 carbon dioxide Inorganic materials 0.000 description 1
- 239000001569 carbon dioxide Substances 0.000 description 1
- 210000004207 dermis Anatomy 0.000 description 1
- 210000002889 endothelial cell Anatomy 0.000 description 1
- 210000003743 erythrocyte Anatomy 0.000 description 1
- 229940012952 fibrinogen Drugs 0.000 description 1
- 210000001117 keloid Anatomy 0.000 description 1
- 238000013532 laser treatment Methods 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 210000000440 neutrophil Anatomy 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B18/18—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by applying electromagnetic radiation, e.g. microwaves
- A61B18/20—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by applying electromagnetic radiation, e.g. microwaves using laser
- A61B18/203—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by applying electromagnetic radiation, e.g. microwaves using laser applying laser energy to the outside of the body
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B2018/00315—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body for treatment of particular body parts
- A61B2018/00452—Skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B2018/00315—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body for treatment of particular body parts
- A61B2018/00452—Skin
- A61B2018/0047—Upper parts of the skin, e.g. skin peeling or treatment of wrinkles
Definitions
- This invention relates to laser treatment arrangements, and more particularly to a laser system for preventing surgical scars on human tissue.
- Scars are a fact of life for most people at one time or another. Such scars may arise as a result of an accident, injury, or surgical procedure. Healing of a scar will begin immediately. The healing process may take a week to a month, depending upon the severity of the skin injury. In an injury where blood vessels are severed along with the dermis and epidermis layers of the skin, the red and white blood cells from those severed vessels leak into the wound site. The blood cells which are called platelets “thrombocytes”, and a blood-clotting protein called fibrinogen, help form a clot of the blood. The cells begin to form a network, and the sides of the injury begin to join together.
- Cellular debris from the epidermis layer begins to invade the area amongst the blood cells. Fibroblasts, or the tissue forming cells, close in around the injury. Within twenty-four hours, the injured or clotted area becomes dehydrated, and a scab is formed at the site. Neutrophils or white blood cells travel from the blood vessels into the injured area and ingest microorganisms, cellular debris, and other foreign material. Division of the epidermal cells begins at the edge of the injury, and those cells begin to build a bridge across that tissue wound. Monocytes, or white blood cells, migrate toward the wound from its surrounding tissue.
- the epidermal cells complete a patch of new skin under the scab that is formed. After a new epidermal surface has been formed, the protective scab is sloughed off. Then the tissue forming cells called fibroblasts begin to build scar tissue with collagen.
- the present invention comprises an arrangement for the prevention of scar formation on a wound or a surgical site.
- the scar prevention is accomplished by the use of an optical radiation apparatus such as a pulse dye laser.
- the pulse dye laser is connected to a handpiece by an elongated flexible optical fiber.
- the laser handpiece is supported at the distal end of the elongated flexible optical fiber and includes a lens for directing a beam of light to a surgical site or a site of an injury.
- the apparatus of the present invention creates a beam of light preferably having a wavelength range of between about 530 nm to about 1000 nm.
- the beam of optical radiation of the present invention preferably has range of pulse width between about 0.1 ms. to 10.0 ms.
- the fluence of the laser may extend from a range of about 2J/cm 2 to about 12J/cm 2 .
- Such a laser pulse is intended to coagulate blood vessels in their initial formation stage to reduce fibroblast activity. Such reduction in fibroblast activity will minimize collagen formation to permit the injury or surgical site to have a more normal looking skin.
- the method of operating the optical radiation apparatus of the present invention includes the application of the optical radiation of wavelength range between about 530 nm and 1000 nm, with a pulse width in a range of about 0.1 ms to 10.0 ms onto the situs of an injury of surgical procedure of a patient, critically within a time constraint of that injury or procedure preferably between about two days after the injury or surgical procedure has taken place, and certainly before two months of that date of injury or surgical procedure.
- coagulating the blood vessels which are typically smaller than 0.1 mm, collagen formation may be minimized and thus scar formation is also minimized or prevented.
- Additional treatment of the surgical site of injury may be provided by the optical radiation apparatus at follow-up intervals, preferable within that two day to two month time period from the occurrence of that injury or surgical procedure or first treatment.
- the utilization of the optical radiation apparatus with a wave length range of between about 535 nm and 1000 nm, and a fluence of about 2J/cm 2 to about 12J/cm 2 within a relatively short time interval after the skin injury, may minimize or prevent any scar tissue formation.
- the invention thus comprises a method for the prevention of a scar on the skin of a patient after the beginning healing of a wound or surgical site, comprising the steps of providing an optical radiation apparatus with an optical radiation handpiece communicating therewith, energyzing the optical radiation apparatus, to provide a beam of light through the handpiece; and directing the beam from the handpiece onto a wound or surgical site after 2 days and before 2 months from the date of injury or surgical procedure.
- the method also includes the beam of light having a wavelength range of about 530 nm to about 1000 nm.
- the method also includes the beam having a fluence range of from 2J/cm 2 to 12J/cm 2 .
- the pulsed dye laser beam also has a beam size of about 3 mm to about 10 mm in diameter.
- the invention also comprises a method for the prevention of a scar on the skin of a patient after the beginning healing of a wound or surgical site, comprising the steps of: providing a pulsed dye laser apparatus with a laser handpiece communicating therewith; energyzing the pulsed dye laser apparatus to provide a beam of laser light; directing the laser beam onto a wound or surgical site after 2 days and before 2 months from the date of injury or surgical procedure, wherein the pulsed dye laser beam preferably has a wavelength range of about 575 nm to about 600 nm., the pulsed dye laser beam having a fluence range of form 2J/cm 2 to 12J/cm 2 , the pulsed dye laser beam having a pulse width range of about 0.1 ms to 1.5 ms, and wherein the pulsed dye laser beam has a beam size range of about 3 mm to about 10 mm in diameter.
- FIG. 1 is a schematic representation of an optical radiation apparatus and an appropriate handpiece directed towards a wound site on a patient, which wound site is shown in cross-section;
- FIGS. 2 A, B, C, and D represent sectional views of a surgical or wound site of a patient, from injury to healing of that site.
- the present invention comprises an arrangement for the prevention of scar formation on a wound or a surgical site.
- the scar prevention is accomplished by the use of an optical radiation apparatus 10 such as a pulse dye laser 12 .
- the pulse dye laser 12 is connected to a laser handpiece 14 by an elongated flexible optical fiber 16 .
- the laser handpiece 14 is supported at the distal end of the elongated flexible optical fiber 16 and includes a lens 18 for directing a beam/pulse of laser light 20 to a surgical site or a site of an injury 22 on the skin of a patient “P”.
- the laser 12 of the present invention creates a beam of light 20 preferably having a wavelength range of about 530 nm to about 1000 nm, but preferably about 585 nm, and a beam size of about 3 mm to 10 mm in diameter.
- the beam of pulse dye laser of the present invention preferably has pulse width range of about 0.1 ms to about 1.5 ms.
- the fluence of the laser 12 may extend from a range of about 2J/cm 2 to about 12J/cm 2 . As shown in FIGS. 1 and 2A, such a laser pulse 20 is intended to coagulate blood vessels 24 in their initial formation stage to reduce fibroblast activity. Such reduction in fibroblast activity will minimize collagen formation to permit the injury or surgical site to have a more normal looking skin.
- the method of operating the pulse dye laser generator in accordance with the principles of the present invention includes the application of a preferred range of the optical laser radiation 20 of 575 nm to 600 nm, with a preferred pulse width range of 0.1 ms to 1.5 ms, preferably applied to the patient “P” between two days after the injury or surgical procedure has taken place, and before two months of that date of injury or surgical procedure.
- a preferred pulse width range 0.1 ms to 1.5 ms
- FIG. 2A shows a side view of a surgical or wound site on a patient “P”, with cellular debris in the wound.
- FIG. 2B shows that wound site with a representation of a forming scab with endothelial cells at the side of the wound beginning to divide.
- FIG. 2C depicts new skin forming under the scab and
- FIG. 2D depicts the continuing formation of scar tissue. It is during the period depicted by FIGS. 2B through 2D when the optical radiation is preferably performed on the patient “P”.
- the invention also includes a method for the prevention of a scar on the skin of a patient after the beginning healing of a wound or surgical site, comprising the steps of providing an optical radiation apparatus 10 with a handpiece 14 communicating therewith, energyzing the optical radiation apparatus 10 to provide a beam of light 20 , directing the light beam 20 onto a wound or surgical site 22 after 2 days and before 2 months from the date of injury or surgical procedure, wherein the light beam has a wavelength range of about 530 nm to 1000 nm, and the light beam has a fluence range of form 2J/cm 2 to 12J/cm 2 .
- the method includes the steps of maintaining the wavelength of the light beam at about 585 nm, and maintaining the pulse width to a range of 0.1 ms to 10 ms.
- the invention also includes a method for the treating a patient “P” with a wound or surgical site in a pre-scarring condition, comprising the steps of providing an optical radiation apparatus 10 with a handpiece 14 communicating therewith, energyzing the optical radiation apparatus 10 to provide a wound treating beam of light 20 , directing the light beam onto a wound or surgical site 22 of the patient “P” after 2 days and before 2 months from the date of injury or surgical procedure, to prevent the occurrence of scar formation at the wound or procedure site.
- the light beam is preferably a pulsed dye laser beam having a wavelength range of about 530 nm to 1000 nm, and a fluence range of from 2J/cm 2 to 12J/cm 2 .
- the laser beam preferably has a pulse width of about 0.1 ms to 10.0 ms, and a beam size of about 3 mm to about 10 mm. in diameter.
Landscapes
- Physics & Mathematics (AREA)
- Health & Medical Sciences (AREA)
- Surgery (AREA)
- Optics & Photonics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Electromagnetism (AREA)
- Biomedical Technology (AREA)
- Heart & Thoracic Surgery (AREA)
- Medical Informatics (AREA)
- Otolaryngology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Radiation-Therapy Devices (AREA)
- Laser Surgery Devices (AREA)
Abstract
The present invention includes a method for the prevention of a scar on the skin of a patient after the beginning healing of a wound or surgical site on that patient. The method comprises the steps of providing an optical radiation apparatus with a handpiece communicating therewith, energyzing the optical radiation apparatus to provide a beam of light, directing the light beam onto a wound or surgical site of a patient after 2 days and before 2 months from the date of injury or surgical procedure to the patient. The beam has a wavelength range of about 530 nm to 1000 nm and the beam has a fluence range of from 2J/cm2 to 12J/cm2. The beam is preferrably generated by a pulsed dye laser apparatus.
Description
- 1. Field of the Invention
- This invention relates to laser treatment arrangements, and more particularly to a laser system for preventing surgical scars on human tissue.
- 2. Prior Art
- Scars are a fact of life for most people at one time or another. Such scars may arise as a result of an accident, injury, or surgical procedure. Healing of a scar will begin immediately. The healing process may take a week to a month, depending upon the severity of the skin injury. In an injury where blood vessels are severed along with the dermis and epidermis layers of the skin, the red and white blood cells from those severed vessels leak into the wound site. The blood cells which are called platelets “thrombocytes”, and a blood-clotting protein called fibrinogen, help form a clot of the blood. The cells begin to form a network, and the sides of the injury begin to join together. Cellular debris from the epidermis layer begins to invade the area amongst the blood cells. Fibroblasts, or the tissue forming cells, close in around the injury. Within twenty-four hours, the injured or clotted area becomes dehydrated, and a scab is formed at the site. Neutrophils or white blood cells travel from the blood vessels into the injured area and ingest microorganisms, cellular debris, and other foreign material. Division of the epidermal cells begins at the edge of the injury, and those cells begin to build a bridge across that tissue wound. Monocytes, or white blood cells, migrate toward the wound from its surrounding tissue.
- Monocytes enter the wound site itself within two to three days after the wound or surgical procedure was created. Those monocytes ingest the remaining foreign material. The epidermal cells complete a patch of new skin under the scab that is formed. After a new epidermal surface has been formed, the protective scab is sloughed off. Then the tissue forming cells called fibroblasts begin to build scar tissue with collagen.
- The epidermis has been restored after about ten days from the injury or surgical procedure, and the scab is typically gone. A tough scar tissue continues to build up, and bundles of collagen accrue along the lines of the original injury or surgical cut.
- Once scars have formed, treatment of them has generally been limited to various resurfacing procedures, such as dermabrasion and chemical peels. Continuous wave carbon dioxide, argon, and pulsed dye lasers have been applied onto scar tissue in an attempt to improve the appearance of a variety of scars and keloids.
- These attempts at scar treatment are performed with the attempt to ensure their removal. Such treatment is often ineffective, short-lived, and sometimes even results in additional scar formation.
- It is an object of the present invention, to provide a unique wound treatment aimed at scar prevention.
- It is a further object of the present invention to provide an efficient cost effective treatment for skin injuries due to accidents or surgical procedures, aimed at preventing the initial formation of scar tissue.
- The present invention comprises an arrangement for the prevention of scar formation on a wound or a surgical site. The scar prevention is accomplished by the use of an optical radiation apparatus such as a pulse dye laser. The pulse dye laser is connected to a handpiece by an elongated flexible optical fiber. The laser handpiece is supported at the distal end of the elongated flexible optical fiber and includes a lens for directing a beam of light to a surgical site or a site of an injury. The apparatus of the present invention creates a beam of light preferably having a wavelength range of between about 530 nm to about 1000 nm. The beam of optical radiation of the present invention preferably has range of pulse width between about 0.1 ms. to 10.0 ms. The fluence of the laser may extend from a range of about 2J/cm 2 to about 12J/cm2. Such a laser pulse is intended to coagulate blood vessels in their initial formation stage to reduce fibroblast activity. Such reduction in fibroblast activity will minimize collagen formation to permit the injury or surgical site to have a more normal looking skin.
- The method of operating the optical radiation apparatus of the present invention includes the application of the optical radiation of wavelength range between about 530 nm and 1000 nm, with a pulse width in a range of about 0.1 ms to 10.0 ms onto the situs of an injury of surgical procedure of a patient, critically within a time constraint of that injury or procedure preferably between about two days after the injury or surgical procedure has taken place, and certainly before two months of that date of injury or surgical procedure. By coagulating the blood vessels, which are typically smaller than 0.1 mm, collagen formation may be minimized and thus scar formation is also minimized or prevented. Additional treatment of the surgical site of injury may be provided by the optical radiation apparatus at follow-up intervals, preferable within that two day to two month time period from the occurrence of that injury or surgical procedure or first treatment.
- Thus it has been shown that the utilization of the optical radiation apparatus with a wave length range of between about 535 nm and 1000 nm, and a fluence of about 2J/cm 2 to about 12J/cm2 within a relatively short time interval after the skin injury, may minimize or prevent any scar tissue formation.
- The invention thus comprises a method for the prevention of a scar on the skin of a patient after the beginning healing of a wound or surgical site, comprising the steps of providing an optical radiation apparatus with an optical radiation handpiece communicating therewith, energyzing the optical radiation apparatus, to provide a beam of light through the handpiece; and directing the beam from the handpiece onto a wound or surgical site after 2 days and before 2 months from the date of injury or surgical procedure. The method also includes the beam of light having a wavelength range of about 530 nm to about 1000 nm. The method also includes the beam having a fluence range of from 2J/cm 2 to 12J/cm2. The pulsed dye laser beam also has a beam size of about 3 mm to about 10 mm in diameter.
- The invention also comprises a method for the prevention of a scar on the skin of a patient after the beginning healing of a wound or surgical site, comprising the steps of: providing a pulsed dye laser apparatus with a laser handpiece communicating therewith; energyzing the pulsed dye laser apparatus to provide a beam of laser light; directing the laser beam onto a wound or surgical site after 2 days and before 2 months from the date of injury or surgical procedure, wherein the pulsed dye laser beam preferably has a wavelength range of about 575 nm to about 600 nm., the pulsed dye laser beam having a fluence range of form 2J/cm 2 to 12J/cm2, the pulsed dye laser beam having a pulse width range of about 0.1 ms to 1.5 ms, and wherein the pulsed dye laser beam has a beam size range of about 3 mm to about 10 mm in diameter.
- The objects and advantages of the present invention will become more apparent when viewed in conjunction with the following drawings, in which:
- FIG. 1 is a schematic representation of an optical radiation apparatus and an appropriate handpiece directed towards a wound site on a patient, which wound site is shown in cross-section; and
- FIGS. 2 A, B, C, and D represent sectional views of a surgical or wound site of a patient, from injury to healing of that site.
- Referring now to the drawings in detail, and particularly to FIG. 1, there is shown the present invention that comprises an arrangement for the prevention of scar formation on a wound or a surgical site. The scar prevention is accomplished by the use of an
optical radiation apparatus 10 such as apulse dye laser 12. Thepulse dye laser 12 is connected to alaser handpiece 14 by an elongated flexibleoptical fiber 16. Thelaser handpiece 14 is supported at the distal end of the elongated flexibleoptical fiber 16 and includes alens 18 for directing a beam/pulse oflaser light 20 to a surgical site or a site of aninjury 22 on the skin of a patient “P”. Thelaser 12 of the present invention creates a beam oflight 20 preferably having a wavelength range of about 530 nm to about 1000 nm, but preferably about 585 nm, and a beam size of about 3 mm to 10 mm in diameter. The beam of pulse dye laser of the present invention preferably has pulse width range of about 0.1 ms to about 1.5 ms. The fluence of thelaser 12 may extend from a range of about 2J/cm2 to about 12J/cm2. As shown in FIGS. 1 and 2A, such alaser pulse 20 is intended to coagulateblood vessels 24 in their initial formation stage to reduce fibroblast activity. Such reduction in fibroblast activity will minimize collagen formation to permit the injury or surgical site to have a more normal looking skin. - The method of operating the pulse dye laser generator in accordance with the principles of the present invention includes the application of a preferred range of the
optical laser radiation 20 of 575 nm to 600 nm, with a preferred pulse width range of 0.1 ms to 1.5 ms, preferably applied to the patient “P” between two days after the injury or surgical procedure has taken place, and before two months of that date of injury or surgical procedure. By coagulating theblood vessels 24 in their formation stage, which vessels then are typically smaller than 0.1 mm, the formation of collagen may be minimized and thus scar formation is also minimized or prevented. Additional treatment of the surgical site of injury may be provided by thepulse dye laser 12 at follow-up intervals, preferable within that two day to two month time period from the first treatment. FIG. 2A shows a side view of a surgical or wound site on a patient “P”, with cellular debris in the wound. FIG. 2B shows that wound site with a representation of a forming scab with endothelial cells at the side of the wound beginning to divide. FIG. 2C depicts new skin forming under the scab and FIG. 2D depicts the continuing formation of scar tissue. It is during the period depicted by FIGS. 2B through 2D when the optical radiation is preferably performed on the patient “P”. - Thus it has been shown that the utilization of the pulse
dye laser apparatus 10 generating alaser beam 22 with a preferred range of wave length of from about 575 nm to about 600 nm, with a preferred wave length of about 585 nm, and a pulse width range of about 0.1 ms to about 1.5 ms, with a preferred pulse width of about 0.5 ms and a fluence of about 2J/cm2 to about 12J/cm2 within a relatively short time interval after the skin injury, may minimize or prevent any scar tissue formation. - The invention also includes a method for the prevention of a scar on the skin of a patient after the beginning healing of a wound or surgical site, comprising the steps of providing an
optical radiation apparatus 10 with ahandpiece 14 communicating therewith, energyzing theoptical radiation apparatus 10 to provide a beam oflight 20, directing thelight beam 20 onto a wound orsurgical site 22 after 2 days and before 2 months from the date of injury or surgical procedure, wherein the light beam has a wavelength range of about 530 nm to 1000 nm, and the light beam has a fluence range of form 2J/cm2 to 12J/cm2. The method includes the steps of maintaining the wavelength of the light beam at about 585 nm, and maintaining the pulse width to a range of 0.1 ms to 10 ms. The invention also includes a method for the treating a patient “P” with a wound or surgical site in a pre-scarring condition, comprising the steps of providing anoptical radiation apparatus 10 with ahandpiece 14 communicating therewith, energyzing theoptical radiation apparatus 10 to provide a wound treating beam oflight 20, directing the light beam onto a wound orsurgical site 22 of the patient “P” after 2 days and before 2 months from the date of injury or surgical procedure, to prevent the occurrence of scar formation at the wound or procedure site. The light beam is preferably a pulsed dye laser beam having a wavelength range of about 530 nm to 1000 nm, and a fluence range of from 2J/cm2 to 12J/cm2. The laser beam preferably has a pulse width of about 0.1 ms to 10.0 ms, and a beam size of about 3 mm to about 10 mm. in diameter.
Claims (12)
1. A method for the prevention of a scar on the skin of a patient after the beginning healing of a wound or surgical site, comprising the steps of:
providing a pulse dye laser apparatus with a laser handpiece communicating therewith;
energyzing said pulse dye laser apparatus to provide a beam of laser light; and
directing said pulse dye laser beam onto a wound or surgical site of a patient after 2 days and before 2 months from the date of injury or surgical procedure on said patient.
2. The method for the prevention of a scar on the skin of a patient as recited in claim 1 , wherein said pulse dye laser beam has a wavelength range of about 575 nm to about 600 nm.
3. The method for the prevention of a scar on the skin of a patient as recited in claim 1 , wherein said pulse dye laser beam has a wavelength of 585 nm.
4. The method for the prevention of a scar on the skin of a patient as recited in claim 2 , wherein said pulsed dye laser beam has a fluence range of from 2J/cm2 to 12J/cm2.
5. The method for the prevention of a scar on the skin of a patient as recited in claim 3 , wherein said pulsed dye laser beam has a pulse width range of about 0.1 ms to 1.5 ms.
6. The method for the prevention of a scar on the skin of a patient as recited in claim 3 , wherein said pulsed dye laser beam has a pulse width of about 0.5 ms.
7. The method for the prevention of a scar on the skin of a patient as recited in claim 4 , wherein said pulsed dye laser beam has a beam size range of about 3 mm to about 10 mm in diameter.
8. A method for the prevention of a scar on the skin of a patient after the beginning healing of a wound or surgical site, comprising the steps of:
providing an optical radiation apparatus with a handpiece communicating therewith;
energyzing said optical radiation apparatus to provide a beam of light;
directing said light beam onto a wound or surgical site after 2 days and before 2 months from the date of injury or surgical procedure, wherein said light beam has a wavelength range of about 530 nm to 1000 nm, said light beam has a fluence range of form 2J/cm2 to 12J/cm2.
9. The method for the prevention of a scar on the skin of a patient after the beginning healing of a wound or surgical site as recited in claim 8 , including the steps of:
maintaining said wavelength of said light beam at about 585 nm; and
maintaining said pulse width to a range of 0.1 ms to 10 ms.
10. A method for the treating a patient with a wound or surgical site in a pre-scarring condition, comprising the steps of:
providing an optical radiation apparatus with a handpiece communicating therewith;
energyzing said optical radiation apparatus to provide a wound treating beam of light;
directing said light beam onto a wound or surgical site of said patient after 2 days and before 2 months from the date of injury or surgical procedure, to prevent the occurrence of scar formation at said wound or procedure site.
11. The method for the treating a patient with a wound or surgical site as recited in claim 10 , wherein said light beam is a pulsed dye laser beam having a wavelength range of about 530 nm to 100 nm, and a fluence range of from 2J/cm2 to 12J/cm2.
12. The method for the treating a patient with a wound or surgical site as recited in claim 11 , wherein said laser beam has a pulse width of about 0.1 ms to 10.0 ms, and a beam size of about 3 mm to about 10 mm in diameter.
Priority Applications (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US09/804,491 US20020087207A1 (en) | 1999-01-15 | 2001-03-12 | Optical radiation treatment for prevention of surgical scars |
| US09/828,996 US6692517B2 (en) | 1999-01-15 | 2001-04-09 | Optical radiation treatment for enhancement of wound healing |
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US09/231,746 US6210426B1 (en) | 1999-01-15 | 1999-01-15 | Optical radiation treatment for prevention of surgical scars |
| US09/804,491 US20020087207A1 (en) | 1999-01-15 | 2001-03-12 | Optical radiation treatment for prevention of surgical scars |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| US09/231,746 Continuation US6210426B1 (en) | 1999-01-15 | 1999-01-15 | Optical radiation treatment for prevention of surgical scars |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| US09/828,996 Continuation-In-Part US6692517B2 (en) | 1999-01-15 | 2001-04-09 | Optical radiation treatment for enhancement of wound healing |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| US20020087207A1 true US20020087207A1 (en) | 2002-07-04 |
Family
ID=22870500
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| US09/231,746 Expired - Fee Related US6210426B1 (en) | 1999-01-15 | 1999-01-15 | Optical radiation treatment for prevention of surgical scars |
| US09/804,491 Abandoned US20020087207A1 (en) | 1999-01-15 | 2001-03-12 | Optical radiation treatment for prevention of surgical scars |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| US09/231,746 Expired - Fee Related US6210426B1 (en) | 1999-01-15 | 1999-01-15 | Optical radiation treatment for prevention of surgical scars |
Country Status (1)
| Country | Link |
|---|---|
| US (2) | US6210426B1 (en) |
Cited By (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6692517B2 (en) * | 1999-01-15 | 2004-02-17 | Cynosure, Inc. | Optical radiation treatment for enhancement of wound healing |
| US20060235493A1 (en) * | 2005-04-14 | 2006-10-19 | Dotson Robert S | Ophthalmic phototherapy device and associated treatment method |
| US20080009839A1 (en) * | 2005-04-14 | 2008-01-10 | Dotson Robert S | Ophthalmic Phototherapy Device and Associated Treatment Method |
| US20080269730A1 (en) * | 2005-04-14 | 2008-10-30 | Dotson Robert S | Ophthalmic Phototherapy Device and Associated Treatment Method |
| US20170027642A1 (en) * | 2015-08-02 | 2017-02-02 | Lumenis Ltd. | Apparatus and cosmetic method for using short pulses for dermatological treatments |
| US9592404B2 (en) | 2005-04-14 | 2017-03-14 | Photospectra Health Sciences, Inc. | Ophthalmic phototherapy device and associated treatment method |
| US10219944B2 (en) | 2014-09-09 | 2019-03-05 | LumiThera, Inc. | Devices and methods for non-invasive multi-wavelength photobiomodulation for ocular treatments |
Families Citing this family (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6547781B1 (en) * | 1996-04-09 | 2003-04-15 | Cynsure, Inc. | Ultra-long flashlamp-excited pulse dye laser for therapy and method therefor |
| KR100376650B1 (en) * | 1996-04-09 | 2003-08-25 | 싸이노슈어, 인코포레이티드 | Alexander laser system for the treatment of skin pathological specimens |
| US6808532B2 (en) * | 2000-12-15 | 2004-10-26 | Dan E. Andersen | Laser treatment for reducing wrinkles |
| US20040082940A1 (en) * | 2002-10-22 | 2004-04-29 | Michael Black | Dermatological apparatus and method |
| US7177695B2 (en) | 2001-12-17 | 2007-02-13 | Cefamoptec Industries, Inc. | Early stage wound healing using electromagnetic radiation |
| KR20050026404A (en) | 2002-06-19 | 2005-03-15 | 팔로마 메디칼 테크놀로지스, 인코포레이티드 | Method and apparatus for photothermal treatment of tissue at depth |
| US7856985B2 (en) | 2005-04-22 | 2010-12-28 | Cynosure, Inc. | Method of treatment body tissue using a non-uniform laser beam |
| US20070036770A1 (en) * | 2005-08-12 | 2007-02-15 | Wagner Darrell O | Biologic device for regulation of gene expression and method therefor |
| WO2007095183A2 (en) * | 2006-02-13 | 2007-08-23 | Reliant Technologies, Inc. | Laser system for treatment of skin laxity |
| US7586957B2 (en) | 2006-08-02 | 2009-09-08 | Cynosure, Inc | Picosecond laser apparatus and methods for its operation and use |
| US20080076836A1 (en) * | 2006-09-01 | 2008-03-27 | Cardiac Pacemakers, Inc | Method and apparatus for using light to enhance cell growth and survival |
| US20080058881A1 (en) * | 2006-09-01 | 2008-03-06 | Cardiac Pacemakers, Inc | Method and system for treating post-mi patients |
| US20080058905A1 (en) * | 2006-09-01 | 2008-03-06 | Wagner Darrell O | Method and apparatus utilizing light as therapy for fungal infection |
| US20090275928A1 (en) * | 2008-05-01 | 2009-11-05 | Solomon Mark P | Suture-less laser blepharoplasty with skin tightening |
| US20100121419A1 (en) * | 2008-11-13 | 2010-05-13 | Ryan Douglas | Control of light sources for light therapies |
| KR102136901B1 (en) | 2012-04-18 | 2020-07-22 | 싸이노슈어, 엘엘씨 | Picosecond laser apparatus and methods for treating target tissues with same |
| WO2014145707A2 (en) | 2013-03-15 | 2014-09-18 | Cynosure, Inc. | Picosecond optical radiation systems and methods of use |
| AU2019225242B2 (en) | 2018-02-26 | 2023-08-10 | Cynosure, Llc | Q-switched cavity dumped sub-nanosecond laser |
| RU2692978C1 (en) * | 2018-10-17 | 2019-06-28 | Федеральное государственное бюджетное учреждение "Научно-клинический центр оториноларингологии Федерального медико-биологического агентства" (ФГБУ НКЦО ФМБА России) | Method of prevention of external nose cicatrical deformities in patients with open injuries of the nose bone frame |
| US11253720B2 (en) | 2020-02-29 | 2022-02-22 | Cutera, Inc. | Dermatological systems and methods with handpiece for coaxial pulse delivery and temperature sensing |
| US10864380B1 (en) | 2020-02-29 | 2020-12-15 | Cutera, Inc. | Systems and methods for controlling therapeutic laser pulse duration |
| RU2767909C1 (en) * | 2021-07-12 | 2022-03-22 | Зоя Александровна Евсюкова | Method for the prevention of pathological scars of postoperative skin wounds |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4672969A (en) * | 1983-10-06 | 1987-06-16 | Sonomo Corporation | Laser healing method |
| US5951596A (en) * | 1991-07-01 | 1999-09-14 | Laser Biotherapy Inc | Biological tissue stimulation by optical energy |
| SE504298C2 (en) * | 1994-01-20 | 1996-12-23 | Biolight Patent Holding Ab | Device for wound healing by light |
| US5464436A (en) * | 1994-04-28 | 1995-11-07 | Lasermedics, Inc. | Method of performing laser therapy |
| US5964749A (en) * | 1995-09-15 | 1999-10-12 | Esc Medical Systems Ltd. | Method and apparatus for skin rejuvenation and wrinkle smoothing |
| US5897549A (en) * | 1995-11-29 | 1999-04-27 | Lumedics, Ltd. | Transformation of unwanted tissue by deep laser heating of water |
-
1999
- 1999-01-15 US US09/231,746 patent/US6210426B1/en not_active Expired - Fee Related
-
2001
- 2001-03-12 US US09/804,491 patent/US20020087207A1/en not_active Abandoned
Cited By (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6692517B2 (en) * | 1999-01-15 | 2004-02-17 | Cynosure, Inc. | Optical radiation treatment for enhancement of wound healing |
| US9782604B2 (en) | 2005-04-14 | 2017-10-10 | Photospectra Health Sciences, Inc. | Ophthalmic phototherapy device and associated treatment method |
| US9592405B2 (en) | 2005-04-14 | 2017-03-14 | Photospectra Health Sciences, Inc. | Ophthalmic phototherapy device and associated treatment method |
| US20080269730A1 (en) * | 2005-04-14 | 2008-10-30 | Dotson Robert S | Ophthalmic Phototherapy Device and Associated Treatment Method |
| US7479136B2 (en) | 2005-04-14 | 2009-01-20 | Dotson Robert S | Ophthalmic phototherapy treatment method |
| US10252078B2 (en) | 2005-04-14 | 2019-04-09 | Photospectra Health Sciences, Inc. | Ophthalmic phototherapy method |
| US9592404B2 (en) | 2005-04-14 | 2017-03-14 | Photospectra Health Sciences, Inc. | Ophthalmic phototherapy device and associated treatment method |
| US20080009839A1 (en) * | 2005-04-14 | 2008-01-10 | Dotson Robert S | Ophthalmic Phototherapy Device and Associated Treatment Method |
| US9974971B2 (en) | 2005-04-14 | 2018-05-22 | Photospectra Health Sciences, Inc | Ophthalmic phototherapy method |
| US9814903B2 (en) | 2005-04-14 | 2017-11-14 | Photospectra Health Services, Inc. | Ophthalmic phototherapy system and associated method |
| US20060235493A1 (en) * | 2005-04-14 | 2006-10-19 | Dotson Robert S | Ophthalmic phototherapy device and associated treatment method |
| US10219944B2 (en) | 2014-09-09 | 2019-03-05 | LumiThera, Inc. | Devices and methods for non-invasive multi-wavelength photobiomodulation for ocular treatments |
| US10596037B2 (en) | 2014-09-09 | 2020-03-24 | LumiThera, Inc. | Devices and methods for non-invasive multi-wavelength photobiomodulation for ocular treatments |
| US10881550B2 (en) | 2014-09-09 | 2021-01-05 | LumiThera, Inc. | Multi-wavelength phototherapy systems and methods for the treatment of damaged or diseased tissue |
| US12336937B2 (en) | 2014-09-09 | 2025-06-24 | LumiThera, Inc. | Multi-wavelength phototherapy devices, systems, and methods for the non-invasive treatment of damaged or diseased tissue |
| US20170027642A1 (en) * | 2015-08-02 | 2017-02-02 | Lumenis Ltd. | Apparatus and cosmetic method for using short pulses for dermatological treatments |
| US10517676B2 (en) * | 2015-08-02 | 2019-12-31 | Lumenis Ltd. | Apparatus and cosmetic method for using short pulses for dermatological treatments |
Also Published As
| Publication number | Publication date |
|---|---|
| US6210426B1 (en) | 2001-04-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US6210426B1 (en) | Optical radiation treatment for prevention of surgical scars | |
| US6692517B2 (en) | Optical radiation treatment for enhancement of wound healing | |
| US5312395A (en) | Method of treating pigmented lesions using pulsed irradiation | |
| US5599342A (en) | Method for treating pigmentation abnormalities using pulsed laser radiation with an elongated cross-section and apparatus for providing same | |
| EP0932431B1 (en) | Wrinkle removal | |
| Kono et al. | Q‐switched ruby versus long‐pulsed dye laser delivered with compression for treatment of facial lentigines in Asians | |
| Nelson et al. | Pilot histologic and ultrastructural study of the effects of medium-depth chemical facial peels on dermal collagen in patients with actinically damaged skin | |
| US20050055071A1 (en) | Method of treating erythematous papules | |
| US6702838B1 (en) | Method of treating hypotrophic scars enlarged pores | |
| Weinstein | Erbium laser resurfacing: current concepts | |
| Orenstein et al. | Treatment of rhinophyma with Er: YAG laser | |
| Goldman et al. | Laser resurfacing of the neck with the erbium: YAG laser | |
| Eberlein et al. | Erbium: YAG laser treatment of post-burn scars: potentials and limitations | |
| US6161546A (en) | System for altering tissue beneath an outer layer of tissue | |
| Harries et al. | Treatment of hereditary haemorrhagic telangiectasia by the pulsed dye laser | |
| Kaplan et al. | Scar revision | |
| EP2981223B1 (en) | Medical laser apparatus | |
| Ho et al. | Prospective study on the treatment of postburn hyperpigmentation by intense pulsed light | |
| Dreno et al. | The benefit of chilling in argon-laser treatment of port-wine stains | |
| Verheyden | Treatment of the facial angiofibromas of tuberous sclerosis | |
| Apfelberg et al. | Benefits of contact and noncontact YAG laser for periorbital hemangiomas | |
| Ayhan et al. | Combined chemical peeling and dermabrasion for deep acne and posttraumatic scars as well as aging face | |
| Thibault | Copper vapor laser and microsclerotherapy of facial telangiectases: A patient questionnaire | |
| Pitanguy et al. | CO 2 laser peeling associated with the'round lifting'technique | |
| Hempel et al. | Combination of rhinoshave and fractional ablative CO2 laser therapy for fine contouring of pronounced rhinophyma–A monocentric retrospective study with long‐term follow‐up |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| STCB | Information on status: application discontinuation |
Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION |